Norepinephrine Regulation of Ventromedial Hypothalamic Nucleus Astrocyte Glycogen Metabolism.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 Jan 2021
Historique:
received: 08 12 2020
revised: 04 01 2021
accepted: 09 01 2021
entrez: 16 1 2021
pubmed: 17 1 2021
medline: 10 4 2021
Statut: epublish

Résumé

The catecholamine norepinephrine (NE) links hindbrain metabolic-sensory neurons with key glucostatic control structures in the brain, including the ventromedial hypothalamic nucleus (VMN). In the brain, the glycogen reserve is maintained within the astrocyte cell compartment as an alternative energy source to blood-derived glucose. VMN astrocytes are direct targets for metabolic stimulus-driven noradrenergic signaling due to their adrenergic receptor expression (AR). The current review discusses recent affirmative evidence that neuro-metabolic stability in the VMN may be shaped by NE influence on astrocyte glycogen metabolism and glycogen-derived substrate fuel supply. Noradrenergic modulation of estrogen receptor (ER) control of VMN glycogen phosphorylase (GP) isoform expression supports the interaction of catecholamine and estradiol signals in shaping the physiological stimulus-specific control of astrocyte glycogen mobilization. Sex-dimorphic NE control of glycogen synthase and GP brain versus muscle type proteins may be due, in part, to the dissimilar noradrenergic governance of astrocyte AR and ER variant profiles in males versus females. Forthcoming advances in the understanding of the molecular mechanistic framework for catecholamine stimulus integration with other regulatory inputs to VMN astrocytes will undoubtedly reveal useful new molecular targets in each sex for glycogen mediated defense of neuronal metabolic equilibrium during neuro-glucopenia.

Identifiants

pubmed: 33451134
pii: ijms22020759
doi: 10.3390/ijms22020759
pmc: PMC7828624
pii:
doi:

Substances chimiques

Receptors, Adrenergic 0
Glycogen 9005-79-2
Glucose IY9XDZ35W2
Norepinephrine X4W3ENH1CV

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK109382
Pays : United States
Organisme : NIH HHS
ID : DK 109382
Pays : United States

Références

Adv Neurobiol. 2019;23:1-16
pubmed: 31667804
ASN Neuro. 2020 Jan-Dec;12:1759091420910933
pubmed: 32233668
J Biol Chem. 2018 May 11;293(19):7099-7107
pubmed: 29483194
J Physiol. 2006 Feb 1;570(Pt 3):469-84
pubmed: 16284073
J Physiol. 2011 Jul 1;589(Pt 13):3383-93
pubmed: 21521757
Front Cell Neurosci. 2013 Apr 10;7:38
pubmed: 23596393
Diabetes. 2013 Dec;62(12):4239-46
pubmed: 23939392
Neuropeptides. 2018 Dec;72:65-74
pubmed: 30396594
Neurosci Biobehav Rev. 2000 May;24(3):295-340
pubmed: 10781693
Int J Mol Sci. 2018 Oct 26;19(11):
pubmed: 30373152
Mol Cell Endocrinol. 2020 Mar 15;504:110703
pubmed: 31931041
Neurochem Res. 2015 Dec;40(12):2493-504
pubmed: 26168779
Physiol Behav. 1997 Jan;61(1):93-100
pubmed: 8976538
Physiol Behav. 2001 Oct;74(3):391-7
pubmed: 11714504
J Neurochem. 2019 Dec;151(5):558-569
pubmed: 31381153
J Neurosci. 1982 Apr;2(4):409-14
pubmed: 6279795
Neuroscience. 2018 May 21;379:103-114
pubmed: 29534973
Brain Res. 1993 Oct 1;623(2):208-14
pubmed: 8221102
Adv Exp Med Biol. 2017;1043:359-383
pubmed: 29224103
J Biol Chem. 1997 Nov 28;272(48):30096-102
pubmed: 9374487
Neuroscience. 2014 Oct 10;278:20-30
pubmed: 25084049
J Cereb Blood Flow Metab. 2012 Jul;32(7):1152-66
pubmed: 22027938
Obes Res. 1995 Dec;3 Suppl 5:735S-740S
pubmed: 8653556
Mol Neurobiol. 2018 Oct;55(10):7872-7885
pubmed: 29478130
Neuroscience. 2009 Dec 15;164(3):1152-60
pubmed: 19744543
Diabetes. 2003 Mar;52(3):663-6
pubmed: 12606506
J Cell Physiol. 2014 Mar;229(3):323-32
pubmed: 24037783
Diabete Metab. 1988 May-Jun;14(3):237-46
pubmed: 2900788
Neurotox Res. 2010 Jul;18(1):94-9
pubmed: 20306167
Prog Brain Res. 1994;100:87-93
pubmed: 7938539
Neuroscience. 2019 Jul 15;411:211-221
pubmed: 31085279
Brain Res. 2019 May 15;1711:48-57
pubmed: 30629946
Front Neuroenergetics. 2012 Mar 02;4:3
pubmed: 22403540
Brain Res. 1990 Dec 17;536(1-2):220-6
pubmed: 2085749
Pflugers Arch. 1990 Jan;415(4):479-83
pubmed: 2315006
Front Neuroendocrinol. 2010 Jan;31(1):32-43
pubmed: 19836412
Curr Opin Clin Nutr Metab Care. 2002 Sep;5(5):539-43
pubmed: 12172478
Nature. 1969 Apr 19;222(5190):282-4
pubmed: 5778398
Neuroendocrinology. 2005;82(1):49-57
pubmed: 16401911
Endocrinol Metab Clin North Am. 2010 Sep;39(3):641-54
pubmed: 20723825
Am J Physiol Regul Integr Comp Physiol. 2005 Dec;289(6):R1777-86
pubmed: 16037122
Cell Metab. 2011 Dec 7;14(6):724-38
pubmed: 22152301
J Neurosci Res. 2003 Oct 15;74(2):179-83
pubmed: 14515346
J Auton Nerv Syst. 1995 Mar 2;51(3):191-7
pubmed: 7769152
Endocrinology. 2006 Jul;147(7):3428-34
pubmed: 16614076
Brain Res Bull. 2015 Jan;110:47-53
pubmed: 25497905
Neuroscience. 2011 Sep 15;191:139-47
pubmed: 21320576
J Neurochem. 2004 May;89(3):537-52
pubmed: 15086511
Dev Neurosci. 1993;15(3-5):306-12
pubmed: 7805583
Neuroscience. 2009 Jan 12;158(1):284-92
pubmed: 19000744
Front Integr Neurosci. 2016 Jan 29;10:2
pubmed: 26858613
Neuropeptides. 2019 Oct;77:101962
pubmed: 31488323
Neuropeptides. 2020 Aug;82:102055
pubmed: 32451071
J Steroid Biochem Mol Biol. 2016 Jun;160:9-14
pubmed: 26472556
Brain Res Bull. 2011 Nov 25;86(5-6):326-33
pubmed: 21963947
Physiol Rep. 2017 Dec;5(23):
pubmed: 29199177
J Cereb Blood Flow Metab. 1993 Jan;13(1):162-9
pubmed: 8417005
J Biol Chem. 2016 Nov 11;291(46):23842-23853
pubmed: 27660393
Acta Neurobiol Exp (Wars). 2020;80(1):57-65
pubmed: 32214275
J Neurochem. 1988 Dec;51(6):1846-51
pubmed: 3183664
J Neurophysiol. 1998 Apr;79(4):1733-45
pubmed: 9535943
Exp Brain Res. 2000 Aug;133(4):547-51
pubmed: 10985689
Neuroscience. 2019 Jun 15;409:253-260
pubmed: 30954669
Curr Opin Neurobiol. 2017 Dec;47:80-85
pubmed: 29054039
Glia. 2015 Jan;63(1):154-62
pubmed: 25130497
FEBS J. 2017 Feb;284(4):546-554
pubmed: 27782369
Brain Res. 1984 Jul 30;307(1-2):109-16
pubmed: 6147174
ASN Neuro. 2020 Jan-Dec;12:1759091420974134
pubmed: 33176438
Brain Res. 2000 Feb 21;856(1-2):37-47
pubmed: 10677609
J Biol Chem. 2018 May 11;293(19):7108-7116
pubmed: 29572349

Auteurs

Karen P Briski (KP)

School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA.

Mostafa M H Ibrahim (MMH)

School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA.

A S M Hasan Mahmood (ASMH)

School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA.

Ayed A Alshamrani (AA)

School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH